| Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors: a … D Hong, L Si, M Jiang, H Shao, W Ming, Y Zhao, Y Li, L Shi Pharmacoeconomics 37 (6), 777-818, 2019 | 70 | 2019 |
| Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment A Monnette, E Chen, D Hong, A Bazzano, S Dixon, WD Arnold, L Shi Orphanet Journal of Rare Diseases 16, 1-13, 2021 | 24 | 2021 |
| Addressing regional differences in diabetes progression: global calibration for diabetes simulation model H Shao, S Yang, C Stoecker, V Fonseca, D Hong, L Shi Value in Health 22 (12), 1402-1409, 2019 | 16 | 2019 |
| Patient-specific factors associated with use of diabetes self-management education and support programs in Louisiana Y Yoshida, D Hong, E Nauman, EG Price-Haywood, AN Bazzano, ... BMJ Open Diabetes Research and Care 9 (Suppl 1), e002136, 2021 | 9 | 2021 |
| 中国各省基本药物集中招标采购方式比较分析 管晓东， 郭志刚， 信枭雄， 洪冬喆， 韩晟， 王宝敏， 史录文 中国卫生政策研究 7 (11), 19-23, 2014 | 7 | 2014 |
| 他氟前列素与拉坦前列素治疗原发性开角型青光眼的成本效果分析 胡春阳， 韩晟， 陈路佳， 张慕禹， 洪冬喆， 杨照， 史录文 中国新药杂志 22 (23), 2831-2836, 2013 | 7 | 2013 |
| The impact of reimbursement for non-face-to-face chronic care management on health utilization among patients with type 2 diabetes in Louisiana Y Shao, C Stoecker, D Hong, E Nauman, V Fonseca, G Hu, AN Bazzano, ... Value in Health 26 (5), 676-684, 2023 | 6 | 2023 |
| The impact of reimbursement for non–face-to-face chronic care management on comprehensive metabolic biomarkers among multimorbid patients with type 2 diabetes Y Shao, C Stoecker, D Hong, E Nauman, V Fonseca, G Hu, AN Bazzano, ... Medical Care 61 (3), 157-164, 2023 | 5 | 2023 |
| Electronic medical record risk modeling of cardiovascular outcomes among patients with type 2 diabetes D Hong, D Fort, L Shi, EG Price-Haywood Diabetes Therapy 12 (7), 2007-2017, 2021 | 3 | 2021 |
| 我国基本药物集中采购量价挂钩实施影响因素分析 郭志刚， 洪冬喆， 刘伊， 郭娜， 王宝敏， 韩晟， 史录文， 管晓东 中国卫生政策研究 8 (12), 1-6, 2015 | 3 | 2015 |
| Does the encounter type matter when defining diabetes complications in electronic health records? D Hong, Y Shen, A Monnette, S Liu, H Shao, E Nauman, ... Medical care 58, S53-S59, 2020 | 2 | 2020 |
| 基于成分数据分析法的医院药品费用结构变化预测研究 洪冬喆， 韩晟， 管晓东， 王宝敏， 詹思延， 史录文 中国新药杂志 24 (9), 965-971, 2015 | 2 | 2015 |
| Assessing patient and caregiver preferences for treatment of haemophilia A: A discrete choice experiment M Benton, AM Patel, L Shi, A Monnette, D Hong, R Kruse‐Jarres, ... Haemophilia 27 (4), e479, 2021 | 1 | 2021 |
| RE4 The IMPACT of reimbursement for non-face-to-face chronic care management on health outcomes and health care utilization among patients with type 2 diabetes in Louisiana Y Shao, D Hong, C Stoecker, E Nauman, A Bazzano, E Kabagambe, ... Value in Health 24, S239, 2021 | 1 | 2021 |
| 42-LB: factors associated with use of diabetes self-management education and support programs in newly diagnosed type 2 diabetes patients in Louisiana Y Yoshida, L Shi, D Hong, E Nauman, G Hu, PT Katzmarzyk, ... Diabetes 69 (Supplement_1), 2020 | 1 | 2020 |
| Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4 … D Hong, L Si, M Jiang, H Shao, W Ming, Y Zhao, Y Li, L Shi PharmacoEconomics 37 (12), 1553-1553, 2019 | 1 | 2019 |
| 我国各省药品集中采购政策落实比较分析 邹武捷， 管晓东， 满春霞， 郭志刚， 马莉莉， 刘伊， 史录文 中国卫生政策研究 9 (9), 35-40, 2016 | 1 | 2016 |
| Effects of Non-Face-to-Face Chronic Care Management on Service Utilization and Outcomes Among US Medicare Beneficiaries with Diabetes D Hong, C Stoecker, Y Shao, E Nauman, V Fonseca, G Hu, AN Bazzano, ... Journal of General Internal Medicine, 1-8, 2024 | | 2024 |
| Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care D Hong, J Avorn, R Wyss, AS Kesselheim JAMA Network Open 7 (1), e2353094-e2353094, 2024 | | 2024 |
| P22 Electronic Medical Record Risk Modeling of Heart Failure Among Patients with Type 2 Diabetes D Hong, D Fort, L Shi, E Price-Haywood Value in Health 25 (7), S291, 2022 | | 2022 |
